DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership

By Muhammad Ali Khalid | February 23, 2026, 3:40 PM

DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds.

On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom, Inc. (NASDAQ:DXCM) from $99 to $95. The analyst maintained his Buy rating on the stock.

DexCom, Inc. (DXCM) Continues to Focus on Glucose Sensors Leadership

Plovanic noted that fourth-quarter results and 2026 outlook met expectations, as the company’s strategy remains unchanged. Management continues to focus on product refinements across the U.S. market, aimed at preserving its leadership in glucose sensors. The firm expects the 15-day G7 to become a dominant product this year, supporting margins over time. Internationally, DexCom, Inc. (NASDAQ:DXCM) plans to offer tiered sensor solutions while continuing efforts to strengthen insurance coverage for CGM.

On February 13, Baird analyst Jeff Johnson reaffirmed his Outperform rating on DexCom, Inc. (NASDAQ:DXCM). The analyst also raised the stock’s price target from $82 to $87, which leads to a revised upside potential of almost 20%. Johnson’s revisions came at the back of the company’s fourth quarter results. With no substantial surprises, he noted certain favorable factors that led him to revise his model.

DexCom, Inc. (NASDAQ:DXCM) is a medical device company that sells continuous glucose monitoring (CGM) systems. These systems efficiently manage diabetes and metabolic conditions by tracking glucose levels every few minutes. Some of its products include DexCom G6, DexCom G7, DexCom Share, DexCom Real-Time API, and DexCom ONE.

While we acknowledge the potential of DXCM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This article is originally published at Insider Monkey.

Mentioned In This Article

Latest News